Publications
Showing entries 81 - 100 out of 115
2015
Oehninger L, Spreckelmeyer S, Holenya P, Meier SM, Can S, Alborzinia H et al. Rhodium(I) N-Heterocyclic Carbene Bioorganometallics as in Vitro Antiproliferative Agents with Distinct Effects on Cellular Signaling. Journal of Medicinal Chemistry. 2015 Dec 24;58(24):9591-9600. doi: 10.1021/acs.jmedchem.5b01159
Meier SM, Muqaku B, Ullmann R, Bileck A, Kreutz D, Mader JC et al. Proteomic and Metabolomic Analyses Reveal Contrasting Anti-Inflammatory Effects of an Extract of Mucor Racemosus Secondary Metabolites Compared to Dexamethasone. PLoS ONE. 2015 Oct 23;10(10):e0140367. doi: 10.1371/journal.pone.0140367
Kuhn PS, Cremer L, Gavriluta A, Jovanovic KK, Filipovic L, Hummer AA et al. Heteropentanuclear Oxalato-Bridged nd-4f (n=4, 5) Metal Complexes with NO Ligand: Synthesis, Crystal Structures, Aqueous Stability and Antiproliferative Activity. Chemistry: A European Journal. 2015 Sept 21;21(39):13703-13713. doi: 10.1002/chem.201502026
Kreutz D, Bileck A, Meier SM, Keppler B, Gerner C. Investigation of novel metal-based anticancer drug candidates’ mechanisms of action by in-depth proteome profiling. In Book of Abstracts. 2015
Hanif M, Moon S, Babak M, Lee B, Huber K, Kubanik M et al. From the selective delivery of organometallic anticancer drugs to targeted therapy and target identification. In Book of Abstracts. 2015. p. 166
Mayer RL, Meier SM, Langbauer C, Gerner C. Reproducible Quantification of Metabolites from Fingertips via Triple-Quadrupole Mass Spectrometry. In Book of Abstracts. 2015
Babak MV, Plazuk D, Meier SM, Arabshahi HJ, Reynisson J, Rychlik B et al. Half-Sandwich Ruthenium(II) Biotin Conjugates as Biological Vectors to Cancer Cells. Chemistry: A European Journal. 2015 Mar 23;21(13):5110-5117. doi: 10.1002/chem.201403974
Nazarov AA, Meier SM, Zava O, Nosova YN, Milaeva ER, Hartinger CG et al. Protein ruthenation and DNA alkylation: chlorambucil-functionalized RAPTA complexes and their anticancer activity. Dalton Transactions. 2015;44(8):3614-3623. doi: 10.1039/c4dt02764g
Babak MV, Meier SM, Huber KVM, Reynisson J, Legin AA, Jakupec MA et al. Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action. Chemical Science. 2015;6(4):2449-2456. doi: 10.1039/c4sc03905j
2014
Moon S, Wiezorek S, Tong K, Lin CH, Meier SM, Hanif M et al. Organometallic anticancer agents. Journal of Biological Inorganic Chemistry. 2014 Aug;19:S730-S730.
Fischer B, Heffeter P, Kryeziu K, Gille L, Meier SM, Berger W et al. Surfactant-mediated activation of the lead anticancer ruthenium compound KP1019 by encapsulation into polymeric nanoparticles. Journal of Biological Inorganic Chemistry. 2014 Aug;19:S802-S802.
Meier SM, Babak MV, Keppler BK, Hartinger CG. Efficiently Detecting Metallodrug-Protein Adducts: Ion Trap versus Time-of-Flight Mass Analyzers. ChemMedChem: chemistry enabling drug discovery. 2014 Jul;9(7):1351-1355. doi: 10.1002/cmdc.201400020
Rathgeb A, Boehm A, Novak MS, Gavriluta A, Doemoetoer O, Tornmasino JB et al. Ruthenium-Nitrosyl Complexes with Glycine, L-Alanine, L-Valine, L-Proline, D-Proline, L-Serine, L-Threonine, and L-Tyrosine: Synthesis, X-ray Diffraction Structures, Spectroscopic and Electrochemical Properties, and Antiproliferative Activity. Inorganic Chemistry. 2014 Mar 3;53(5):2718-2729. doi: 10.1021/ic4031359
Pichler V, Goeschl S, Meier SM, Alexander R, Jakupec MA, Galanski MS et al. Asymmetric and symmetric Pt-IV complexes: new insights into the influence of the equatorial ligands sphere on reactivity and stability. Journal of Biological Inorganic Chemistry. 2014 Mar;19(S1):598. doi: 10.1007/s00775-014-1095-8
Meier SM, Pichler V, Novak M, Jirkovsky E, Jakupec MA, Arion VA et al. Novel Metal(II)-Arene 2-Pyridinecarbothioamides: A Rationale to Orally Active Organometallic Anticancer Agents. Journal of Biological Inorganic Chemistry. 2014 Mar;19(Supplement 1):S587-S587. Meeting Abstract 1702139.
Meier SM, Novak MS, Kandioller W, Jakupec MA, Roller A, Keppler BK et al. Aqueous chemistry and antiproliferative activity of a pyrone-based phosphoramidate Ru(arene) anticancer agent. Dalton Transactions. 2014;43(26):9851-9855. doi: 10.1039/c4dt00569d
Pichler V, Göschl S, Meier SM, Roller A, Jakupec M, Galanski MS et al. Asymmetric and symmetric PtIV complexes: new insights into the influence of the equatorial ligands sphere on reactivity and stability. Journal of Biological Inorganic Chemistry. 2014;19 Suppl.:S598.
Fischer B, Heffeter P, Kryeziu K, Gille L, Meier SM, Berger W et al. Poly(lactic acid) nanoparticles of the lead anticancer ruthenium compound KP1019 and its surfactant-mediated activation. Dalton Transactions. 2014;43(3):1096-1104. doi: 10.1039/c3dt52388h
2013
Hanif M, Meier SM, Nazarov AA, Risse J, Legin A, Casini A et al. Influence of the π-coordinated arene on the anticancer activity of ruthenium(II) carbohydrate organometallic complexes. Frontiers in Chemistry. 2013 Oct 31;1:27. doi: 10.3389/fchem.2013.00027
Primik MF, Goeschl S, Meier SM, Eberherr N, Jakupec MA, Enyedy EA et al. Dicopper(II) and Dizinc(II) Complexes with Nonsymmetric Dinucleating Ligands Based on Indolo[3,2-c]quinolines: Synthesis, Structure, Cytotoxicity, and Intracellular Distribution. Inorganic Chemistry. 2013 Sept 2;52(17):10137-10146. doi: 10.1021/ic401573d
Showing entries 81 - 100 out of 115